Cargando…

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience

INTRODUCTION: Acromegaly is a chronic disease with systemic complications. Disease onset is insidious and consequently typically burdened by diagnostic delay. A longer diagnostic delay induces more frequently cardiovascular, respiratory, metabolic, neuropsychiatric and musculoskeletal comorbidities....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiloiro, Sabrina, Giampietro, Antonella, Gagliardi, Irene, Bondanelli, Marta, Veleno, Miriam, Ambrosio, Maria Rosaria, Zatelli, Maria Chiara, Pontecorvi, Alfredo, Giustina, Andrea, De Marinis, Laura, Bianchi, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362053/ https://www.ncbi.nlm.nih.gov/pubmed/35922724 http://dx.doi.org/10.1007/s11102-022-01266-4

Ejemplares similares

Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study
por: Gagliardi, Irene, et al.
Publicado: (2021)

MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020)

SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review
por: Menotti, Sara, et al.
Publicado: (2023)

Gastrointestinal carcinoma first presenting as pituitary mass: recognition of a rare case and multidisciplinary approach for the management of pituitary metastases
por: Costanza, Flavia, et al.
Publicado: (2023)

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

Long-term low-dose tolvaptan efficacy and safety in SIADH
por: Bondanelli, Marta, et al.
Publicado: (2023)

THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
por: Costanza, Flavia, et al.
Publicado: (2023)

THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

Hypeprolactinemia: still an insidious diagnosis
por: Aliberti, Ludovica, et al.
Publicado: (2020)

Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
por: Bima, Chiara, et al.
Publicado: (2021)

Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?
por: Gobbo, Alberto, et al.
Publicado: (2022)

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
por: Aliberti, Ludovica, et al.
Publicado: (2022)

Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors
por: Mattogno, Pier Paolo, et al.
Publicado: (2021)

SUN-LB076 Potential Role of Gallium-68-Peptides and Fluorine-18-FDG PET/CT and Ki67 in Patients with Post-Surgical Residual Pituitary Adenoma
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Evaluation of a Nep-Score Threshold and the Derived Nep-D Score in Predicting Survival of Patients With Typical and Atypical Bronchial Carcinoids
por: Gagliardi, Irene, et al.
Publicado: (2021)

Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
por: Giustina, A., et al.
Publicado: (2014)

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
por: Bianchi, Antonio, et al.
Publicado: (2023)

Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

THU093 Pituitary Enlargement And Hypopituitarism In Patients Treated With Immune Checkpoint Inhibitors: Two Sides Of The Same Coin?
por: Menotti, Sara, et al.
Publicado: (2023)

Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget
por: Gagliardi, Irene, et al.
Publicado: (2021)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
por: Bianchi, Antonio, et al.
Publicado: (2013)

Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience
por: Gagliardi, Irene, et al.
Publicado: (2022)

First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Pegvisomant in acromegaly: an update
por: Giustina, A., et al.
Publicado: (2017)

Investigation of COVID-19 infection in subjects with Klinefelter syndrome
por: Aliberti, L., et al.
Publicado: (2022)

Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life
por: Cangiano, Biagio, et al.
Publicado: (2022)

Role of Pituitary Tumour Transforming Gene 1 in Medullary Thyroid Carcinoma
por: Zatelli, Maria Chiara, et al.
Publicado: (2010)

Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line
por: Gentilin, E., et al.
Publicado: (2023)

THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)

Neoadjuvant PRRT for advanced pNEN: an unusual highlander
por: Zanata, Isabella, et al.
Publicado: (2021)

Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
por: Giustina, Andrea, et al.
Publicado: (2012)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major
por: Carnevale, Aldo, et al.
Publicado: (2022)

The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case
por: Costanza, Flavia, et al.
Publicado: (2023)

NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids
por: Gagliardi, Irene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ribusnlj8j3hu35k8f385nhc8t